# Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

> **NCT02785172** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 154 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** IDP-118 Vehicle Lotion
- **DRUG:** IDP-118 Vehicle Cream
- **DRUG:** IDP-118 Lotion
- **DRUG:** Ultravate Cream

## Key facts

- **NCT ID:** NCT02785172
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785172, "Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02785172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*